COMMUNIQUÉS West-GlobeNewswire

Thought Leadership & Innovation Foundation Announces Bill Oldham’s Appointment to the NIH Interagency Autism Coordinating Committee
05/02/2026
LEESBURG, Va., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Thought Leadership & Innovation Foundation (TLI) today announced that its Founder and President, Bill Oldham , has been appointed to the NIH Interagency Autism [...]
Lighthouse Autism Center Announces Opening of New Cedar Falls, IA Location
05/02/2026
Premier ABA Provider Expands Services with 50th Location Nationwide CEDAR FALLS, Iowa, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Lighthouse Autism Center, a leading provider of center-based Applied Behavior Analysis (ABA) [...]
Introducing Community by Keto-Mojo – A Supportive, Expert-Led Space to Help People Succeed in Ketosis and Beyond
05/02/2026
NAPA, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sustainable health doesn’t happen in isolation—it thrives in community. While millions attempt keto, low-carb, or fasting lifestyles to improve their metabolic health, [...]
Le plan d’action Diriger pour combler l’écart demande aux acteurs au pouvoir partout au pays de réduire les disparités en matière de santé des femmes
05/02/2026
Un nouveau plan national présente comment le Canada peut améliorer la santé des femmes et renforcer leur participation à la société afin de faire de nouveaux gains économiques TORONTO, 05 févr. 2026 (GLOBE NEWSWIRE) -- [...]
Blueprint for Action Calls for Pan-Canadian Leadership to Close the Women’s Health Gap
05/02/2026
New national plan outlines how Canada can improve women’s health, strengthen participation, and unlock economic gains TORONTO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Women’s Health Collective Canada (WHCC) today released [...]
Novo Nordisk issues statement on illegal mass compounding and deceptive advertising by Hims & Hers
05/02/2026
Bagsværd, Denmark and Plainsboro, NJ, 5 February 2026 – Novo Nordisk today issued the following statement regarding the announcement by Hims & Hers that they will unlawfully mass-market an unapproved, inauthentic, [...]
Virbac : Déclaration d'actions et de droits de vote 01/2026
05/02/2026
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Guerbet : 2025 revenue.
05/02/2026
2025 revenue Full-year revenue: €786.4 million, down 3.5% at CER 1 and on a like-for-like basis 2 , largely due to the fall in business in France A decline in Q4 of 5.6% at CER and on a like-for-like basis, linked to [...]
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
05/02/2026
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for [...]
Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year
05/02/2026
Expected record fiscal second quarter revenue increase driven by expanding customer base and strong growth across all product categories Reader sales expected to post year-over-year growth of more than 100% in fiscal Q2 [...]
RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer
05/02/2026
Appointment Strengthens RenovoRx’s C-Suite Leadership to Support Commercial Growth of RenovoCath® MOUNTAIN VIEW, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a [...]
IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY
05/02/2026
Strategic Restructuring Eliminates Expenses Not Essential to the Phase 3 Study Khursheed Anwer, Ph.D., Executive Vice President and Chief Scientific Officer, will retire after nearly 12 years at the company Phase 3 [...]
FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia
05/02/2026
HOUSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the [...]
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
05/02/2026
Southlake, TX, Feb. 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. ( Nasdaq: HSCS; HSCSW ) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advancing electrocardiography (“ECG” or [...]
Alumis to Participate in Upcoming February Investor Conferences
05/02/2026
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today [...]
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health
05/02/2026
Milestone reflects accelerating adoption of innovative, non-surgical treatment options for uterine conditions TORONTO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “ [...]
Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption
05/02/2026
Participating at the Society of Interventional Oncology Conference Will Allow the Company to Share Practical Insights and Personal Experiences HINGHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. ( [...]
In a Defining Election Year, MAPS Releases Policy Guidebook to Shape the Future of Psychedelic Reform
05/02/2026
New resource offers legislators, advocates, and communities a roadmap for creating safe, equitable, and evidence-based psychedelic policies WASHINGTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- With the United States in a [...]
ICU Medical Announces Time of Fourth Quarter 2025 Earnings Conference Call
05/02/2026
SAN CLEMENTE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter [...]

Pages